Oak Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-782,189
| Closed | -$12.3M | – | 153 |
|
|
2019
Q1 | $12.3M | Buy |
782,189
+21,181
| +3% | +$374K | 0.75% | 41 |
|
|
2018
Q4 | $11.7M | Buy |
761,008
+75,980
| +11% | +$1.56M | 0.83% | 41 |
|
|
2018
Q3 | $14.8M | Buy |
685,028
+127,215
| +23% | +$2.95M | 0.9% | 39 |
|
|
2018
Q2 | $13.6M | Buy |
557,813
+5,030
| +0.9% | +$103K | 0.91% | 37 |
|
|
2018
Q1 | $9.45M | Buy |
552,783
+169,808
| +44% | +$3.32M | 0.66% | 51 |
|
|
2017
Q4 | $7.26M | Sell |
382,975
-1,249
| -0.3% | -$18.8K | 0.51% | 57 |
|
|
2017
Q3 | $6.76M | Buy |
384,224
+4,300
| +1% | +$96.8K | 0.5% | 59 |
|
|
2017
Q2 | $12.6M | Buy |
379,924
+2,114
| +0.6% | +$65.4K | 0.95% | 36 |
|
|
2017
Q1 | $12.1M | Buy |
377,810
+7,896
| +2% | +$269K | 0.97% | 33 |
|
|
2016
Q4 | $13.4M | Sell |
369,914
-24,824
| -6% | -$991K | 1.32% | 23 |
|
|
2016
Q3 | $16.9M | Buy |
394,738
+38,015
| +11% | +$1.98M | 1.74% | 17 |
|
|
2016
Q2 | $17.9M | Buy |
356,723
+881
| +0.2% | +$46.9K | 2.15% | 14 |
|
|
2016
Q1 | $19M | Sell |
355,842
-2,109
| -0.6% | -$124K | 2.33% | 14 |
|
|
2015
Q4 | $23.5M | Sell |
357,951
-20,148
| -5% | -$1.25M | 2.8% | 11 |
|
|
2015
Q3 | $21.3M | Sell |
378,099
-5,864
| -2% | -$380K | 2.83% | 9 |
|
|
2015
Q2 | $22.7M | Sell |
383,963
-2,450
| -0.6% | -$151K | 2.76% | 9 |
|
|
2015
Q1 | $24.1M | Buy |
386,413
+9,841
| +3% | +$572K | 2.9% | 8 |
|
|
2014
Q4 | $21.7M | Buy |
376,572
+1,226
| +0.3% | +$68.3K | 2.59% | 10 |
|
|
2014
Q3 | $20.2M | Buy |
375,346
+14,940
| +4% | +$792K | 2.49% | 12 |
|
|
2014
Q2 | $18.9M | Buy |
360,406
+12,056
| +3% | +$616K | 2.31% | 13 |
|
|
2014
Q1 | $18.4M | Sell |
348,350
-93,899
| -21% | -$4.34M | 2.28% | 14 |
|
|
2013
Q4 | $17.7M | Buy |
+442,249
| New | +$17.4M | 1.92% | 18 |
|
|
2013
Q2 | $18.1M | Buy |
+462,508
| New | +$18M | 2.16% | 18 |
|
Other funds holding TEVA
ACM
